scholarly journals Optimal Size Criterion for Malignant Lymph Nodes and a Novel Lymph Node Clinical Staging System for Unresectable Esophageal Squamous Cell Carcinoma: Evaluation by Multislice Spiral Computed Tomography

2021 ◽  
Vol 12 (21) ◽  
pp. 6454-6464
Author(s):  
Hang Wang ◽  
Zheng Lin ◽  
Yimin Lin ◽  
Ruigang Huang ◽  
Moliang Qiu ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Squamous Cell Carcinoma ◽  
Lymph Node ◽  
Staging System ◽  
Clinical Staging ◽  
Optimal Size ◽  
Spiral Computed ◽  
Clinical Staging System ◽  
Size Criterion ◽  
Malignant Lymph Nodes

Revision of the clinical staging system for cancer of the larynx

Cancer ◽  
1973 ◽  
Vol 31 (1) ◽  
pp. 72-80 ◽  
Author(s):  
Robert R. Smith ◽  
Ralph Caulk ◽  
Edgar Frazell ◽  
Paul H. Holinger ◽  
William S. Maccomb ◽  
...  
Keyword(s):  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

A proposed clinical staging system for obesity

2009 ◽  
Vol 33 (3) ◽  
pp. 289-295 ◽  
Author(s):  
A M Sharma ◽  
R F Kushner
Keyword(s):  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

scholarly journals Evaluation of lymph node metastases in gastric cancer with spiral computed tomography

2006 ◽  
Vol 14 (31) ◽  
pp. 3060
Author(s):  
Zhi-Qing Zhao ◽  
Ke-Guo Zheng ◽  
Jing-Xian Shen ◽  
Wei Wang ◽  
Zi-Ping Li ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Computed Tomography ◽  
Lymph Node ◽  
Lymph Node Metastases ◽  
Spiral Computed Tomography ◽  
Spiral Computed ◽  
Node Metastases

A TNM-Based Clinical Staging System of Ocular Adnexal Lymphomas

2009 ◽  
Vol 133 (8) ◽  
pp. 1262-1267 ◽  
Author(s):  
Sarah E. Coupland ◽  
Valerie A. White ◽  
Jack Rootman ◽  
Bertil Damato ◽  
Paul T. Finger
Keyword(s):  
Prognostic Significance ◽  
Staging System ◽  
Clinical Staging ◽  
Disease Extent ◽  
Non Hodgkin Lymphoma ◽  
Ann Arbor ◽  
Data Points ◽  
Specific Factors ◽  
Clinical Staging System ◽  
User Friendly

Abstract Context.—The ocular adnexal lymphomas (OAL) arise in the conjunctiva, orbit, lacrimal gland, and eyelids. To date, they have been clinically staged using the Ann Arbor staging system, first designed for Hodgkin and later for nodal, non–Hodgkin lymphoma. The Ann Arbor system has several shortcomings, particularly when staging extranodal non– Hodgkin lymphomas, such as OAL, which show different dissemination patterns from nodal lymphomas. Objective.—To describe the first TNM-based clinical staging system for OAL. Design.—Retrospective literature review. Results.—We have developed, to our knowledge, the first American Joint Committee on Cancer–International Union Against Cancer TNM-based staging system for OAL to overcome the limitations of the Ann Arbor system. Our staging system defines disease extent more precisely within the various anatomic compartments of the ocular adnexa and allows for analysis of site-specific factors not addressed previously. It aims to facilitate future studies by identifying clinical and histomorphologic features of prognostic significance. This system is for primary OAL only and is not intended for intraocular lymphomas. Conclusions.—Our TNM-based staging system for OAL is a user-friendly, anatomic documentation of disease extent, which creates a common language for multicenter and international collaboration. Data points will be collected with the aim of identifying biomarkers to be incorporated into the staging system.

A rational clinical staging system for childhood rhabdomyosarcoma.

1984 ◽  
Vol 2 (2) ◽  
pp. 135-139 ◽  
Author(s):  
S S Donaldson ◽  
J A Belli
Keyword(s):  
Natural History ◽  
Therapeutic Strategy ◽  
Tumor Volume ◽  
Staging System ◽  
Clinical Staging ◽  
Tumor Node Metastasis ◽  
Node Metastasis ◽  
History Of ◽  
Clinical Staging System ◽  
Childhood Rhabdomyosarcoma

There is a need for a rational and useful staging system for childhood rhabdomyosarcoma that predicts prognosis based on the biology and natural history of the disease. Important factors to consider are age, histology, tumor volume, extent of invasion, and lymphatic involvement. A clinical staging system based on a classical tumor/node/metastasis status, and which accounts for natural history as a function of site of primary, local invasion, and lymphatic or hematogenous metastases is presented. This staging system eliminates the requirement that stage is assigned following an initial therapeutic strategy and removing the implication that prognosis is determined by that strategy.

Sign in / Sign up

Export Citation Format

Share Document